Interim Order No. 2 Respecting Clinical Trials for Medical Devices and Drugs Relating to COVID-19
The Interim Order (IO) No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada